BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 12822344)

  • 1. [Osteogenic potential of three kinds of calcium phosphate ceramics as carriers for recombinant human morphogenetic protein-2 in vivo].
    Long HQ; Li FB; Wang YJ; Liao WM; Wang HX
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2003 May; 17(3):180-4. PubMed ID: 12822344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of ceramics composed of different hydroxyapatite to tricalcium phosphate ratios as carriers for rhBMP-2.
    Alam MI; Asahina I; Ohmamiuda K; Takahashi K; Yokota S; Enomoto S
    Biomaterials; 2001 Jun; 22(12):1643-51. PubMed ID: 11374466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experimental study of the effect of new bone formation on new type artificial bone composed of bioactive ceramics].
    Zhu M; Zeng Y; Sun T; Peng Q
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2005 Mar; 19(3):174-7. PubMed ID: 15828468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ectopic bone formation associated with recombinant human bone morphogenetic proteins-2 using absorbable collagen sponge and beta tricalcium phosphate as carriers.
    Kim CS; Kim JI; Kim J; Choi SH; Chai JK; Kim CK; Cho KS
    Biomaterials; 2005 May; 26(15):2501-7. PubMed ID: 15585252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ectopic osteoinduction and early degradation of recombinant human bone morphogenetic protein-2-loaded porous beta-tricalcium phosphate in mice.
    Liang G; Yang Y; Oh S; Ong JL; Zheng C; Ran J; Yin G; Zhou D
    Biomaterials; 2005 Jul; 26(20):4265-71. PubMed ID: 15683650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of a fibrin-fibronectin/beta-tricalcium phosphate/recombinant human bone morphogenetic protein-2 system on bone formation in rat calvarial defects.
    Hong SJ; Kim CS; Han DK; Cho IH; Jung UW; Choi SH; Kim CK; Cho KS
    Biomaterials; 2006 Jul; 27(20):3810-6. PubMed ID: 16574220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ectopic bone formation by biphasic calcium phosphate (BCP) combined with recombinant human bone morphogenetic protein-2 (rhBMP-2).
    Oda S; Kinoshita A; Higuchi T; Shizuya T; Ishikawa I
    J Med Dent Sci; 1997 Sep; 44(3):53-62. PubMed ID: 9608282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interactions between rat-adipose-derived stromal cells, recombinant human bone morphogenetic protein-2, and beta-tricalcium phosphate play an important role in bone tissue engineering.
    E LL; Xu LL; Wu X; Wang DS; Lv Y; Wang JZ; Liu HC
    Tissue Eng Part A; 2010 Sep; 16(9):2927-40. PubMed ID: 20486786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone inductive properties of rhBMP-2 loaded porous calcium phosphate cement implants inserted at an ectopic site in rabbits.
    Kroese-Deutman HC; Ruhé PQ; Spauwen PH; Jansen JA
    Biomaterials; 2005 Apr; 26(10):1131-8. PubMed ID: 15451632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of recombinant human bone morphogenetic protein-4 with carriers in rat calvarial defects.
    Ahn SH; Kim CS; Suk HJ; Lee YJ; Choi SH; Chai JK; Kim CK; Han SB; Cho KS
    J Periodontol; 2003 Jun; 74(6):787-97. PubMed ID: 12886988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of recombinant human bone morphogenetic protein-4 dose on bone formation in a rat calvarial defect model.
    Pang EK; Im SU; Kim CS; Choi SH; Chai JK; Kim CK; Han SB; Cho KS
    J Periodontol; 2004 Oct; 75(10):1364-70. PubMed ID: 15562914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of bone morphogenetic protein and proportion of hydroxyapatite on new bone formation in biphasic calcium phosphate graft: two pilot studies in animal bony defect model.
    Yun PY; Kim YK; Jeong KI; Park JC; Choi YJ
    J Craniomaxillofac Surg; 2014 Dec; 42(8):1909-17. PubMed ID: 25443868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of biphasic calcium phosphate ceramics impregnated with rhBMP-2 as bone substitutes.
    Alam I; Asahina I; Ohmamiuda K; Enomoto S
    J Biomed Mater Res; 2001 Jan; 54(1):129-38. PubMed ID: 11077412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carrier dependent cell differentiation of bone morphogenetic protein-2 induced osteogenesis and chondrogenesis during the early implantation stage in rats.
    Takita H; Vehof JW; Jansen JA; Yamamoto M; Tabata Y; Tamura M; Kuboki Y
    J Biomed Mater Res A; 2004 Oct; 71(1):181-9. PubMed ID: 15368268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone morphogenetic protein-2 enhances bone formation when delivered by a synthetic matrix containing hydroxyapatite/tricalciumphosphate.
    Jung RE; Weber FE; Thoma DS; Ehrbar M; Cochran DL; Hämmerle CH
    Clin Oral Implants Res; 2008 Feb; 19(2):188-95. PubMed ID: 18067602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ectopic bone formation in mice associated with a lactic acid/dioxanone/ethylene glycol copolymer-tricalcium phosphate composite with added recombinant human bone morphogenetic protein-2.
    Kato M; Namikawa T; Terai H; Hoshino M; Miyamoto S; Takaoka K
    Biomaterials; 2006 Jul; 27(21):3927-33. PubMed ID: 16564087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hollow calcium phosphate microcarriers for bone regeneration: in vitro osteoproduction and ex vivo mechanical assessment.
    Santoni BG; Pluhar GE; Motta T; Wheeler DL
    Biomed Mater Eng; 2007; 17(5):277-89. PubMed ID: 17851170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast growth factor-2 augments recombinant human bone morphogenetic protein-2-induced osteoinductive activity.
    Tanaka E; Ishino Y; Sasaki A; Hasegawa T; Watanabe M; Dalla-Bona DA; Yamano E; van Eijden TM; Tanne K
    Ann Biomed Eng; 2006 May; 34(5):717-25. PubMed ID: 16568346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of fusion rate induced by different dosages of Escherichia coli-derived recombinant human bone morphogenetic protein-2 using hydroxyapatite carrier.
    Lee JH; Yu CH; Yang JJ; Baek HR; Lee KM; Koo TY; Chang BS; Lee CK
    Spine J; 2012 Mar; 12(3):239-48. PubMed ID: 22341396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant growth/differentiation factor-5 (GDF-5) stimulates osteogenic differentiation of marrow mesenchymal stem cells in porous hydroxyapatite ceramic.
    Shimaoka H; Dohi Y; Ohgushi H; Ikeuchi M; Okamoto M; Kudo A; Kirita T; Yonemasu K
    J Biomed Mater Res A; 2004 Jan; 68(1):168-76. PubMed ID: 14661262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.